Bajaj Healthcare Ltd Stock Price Today (NSE: BAJAJHCARE)
Fundamental Score
Bajaj Healthcare Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Bajaj Healthcare Ltd share price today is ₹360.45, up +0.00% on NSE/BSE as of 17 February 2026. Bajaj Healthcare Ltd (BAJAJHCARE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹1.35K (Cr). The 52-week high for BAJAJHCARE share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 26.45x, BAJAJHCARE is currently trading below its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 10.69% and a debt-to-equity ratio of 0.49.
Bajaj Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Bajaj Healthcare Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Bajaj Healthcare Share Price: A Financial Stability Analysis
The pharmaceutical industry, often touted as recession-proof, faces constant headwinds from stringent regulations and fluctuating raw material costs. This analysis examines the financial stability of Bajaj Healthcare, focusing on its key metrics. Currently, the Bajaj Healthcare share price stands at ₹373.5. A crucial factor to consider is its Price-to-Earnings (PE) ratio of 26.45, which provides insight into investor expectations regarding future earnings growth.
The Return on Capital Employed (ROCE) for Bajaj Healthcare is 11.44%. While this figure indicates profitability in relation to invested capital, its impact on the company's economic moat – its ability to maintain competitive advantages – warrants careful consideration. A higher ROCE often signifies a stronger moat, as it suggests the company is efficiently utilizing capital to generate profits, potentially discouraging competitors. However, an 11.44% ROCE suggests a moderately sized moat, not indicative of overwhelming competitive dominance.
Comparing Bajaj Healthcare with its peers offers further context. While a detailed assessment requires comprehensive financial data, a qualitative comparison of management quality with a peer like
Mankind Pharma Ltd can be insightful. Factors such as strategic decision-making, capital allocation efficiency, and risk management within Mankind Pharma Ltd, when compared to Bajaj Healthcare, provide a valuable, though subjective, benchmark for overall business acumen. The strategic choices and execution demonstrated by leadership significantly affect long-term sustainability.In contrast to
Mankind Pharma Ltd, and considering Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd, the company's PE multiple of 26.45 requires ongoing evaluation within the context of sector performance, considering that Bajaj Healthcare is positioned within specialty chemicals and intermediaries. Further in-depth analysis of debt, cash flow and balance sheet is necessary to conclude the stability of the Bajaj Healthcare stock price. It is important to note that this analysis is a segment of a broader 80-parameter fundamental audit, overseen and verified by Sweta Mishra, to ensure a comprehensive evaluation of Bajaj Healthcare's financial standing.Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Bajaj Healthcare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of BAJAJHCARE across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Operating Margins (17.53%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Robust Profit Growth (49.28%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Balanced Promoter Holding (59.19%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Negative Free Cash Flow (₹-175.36 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 4.11%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Bajaj Healthcare Ltd Financial Statements
Comprehensive financial data for Bajaj Healthcare Ltd including income statement, balance sheet and cash flow
About BAJAJHCARE (Bajaj Healthcare Ltd)
Bajaj Healthcare Ltd (BAJAJHCARE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹1.35K (Cr). Bajaj Healthcare Ltd has delivered a Return on Equity (ROE) of 10.69% and a ROCE of 11.44%. The debt-to-equity ratio stands at 0.49, reflecting the company's capital structure. Investors tracking BAJAJHCARE share price can monitor key metrics including P/E ratio, promoter holding of 59.19%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
BAJAJHCARE Share Price: Frequently Asked Questions
What is the current share price of Bajaj Healthcare Ltd (BAJAJHCARE)?
As of 17 Feb 2026, 10:08 am IST, Bajaj Healthcare Ltd share price is ₹360.45. The BAJAJHCARE stock has a market capitalisation of ₹1.35K (Cr) on NSE/BSE.
Is BAJAJHCARE share price Overvalued or Undervalued?
BAJAJHCARE share price is currently trading at a P/E ratio of 26.45x, compared to the industry average of 31.77x. Based on this relative valuation, the Bajaj Healthcare Ltd stock appears to be Undervalued against its sector peers.
What is the 52-week high and low of BAJAJHCARE share price?
The 52-week high of BAJAJHCARE share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Bajaj Healthcare Ltd share price?
Key factors influencing BAJAJHCARE share price include quarterly earnings growth (Sales Growth: 11.14%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Bajaj Healthcare Ltd a good stock for long-term investment?
Bajaj Healthcare Ltd shows a 5-year Profit Growth of 9.56% and an ROE of 10.69%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.49 before investing in BAJAJHCARE shares.
How does Bajaj Healthcare Ltd compare with its industry peers?
Bajaj Healthcare Ltd competes with major peers in the Pharmaceuticals. Investors should compare BAJAJHCARE share price P/E of 26.45x and ROE of 10.69% against the industry averages to determine competitive standing.
What is the P/E ratio of BAJAJHCARE and what does it mean?
BAJAJHCARE share price has a P/E ratio of 26.45x compared to the industry average of 31.77x. Investors pay ₹26 for every ₹1 of annual earnings.
How is BAJAJHCARE performing according to Bull Run's analysis?
BAJAJHCARE has a Bull Run fundamental score of 46.1/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does BAJAJHCARE belong to?
BAJAJHCARE operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Bajaj Healthcare Ltd share price.
What is Return on Equity (ROE) and why is it important for BAJAJHCARE?
BAJAJHCARE has an ROE of 10.69%, which shows decent profitability but room for improvement. ROE measures how efficiently Bajaj Healthcare Ltd generates profits from shareholders capital.
How is BAJAJHCARE debt-to-equity ratio and what does it indicate?
BAJAJHCARE has a debt-to-equity ratio of 0.49, which indicates moderate leverage that should be monitored.
What is BAJAJHCARE dividend yield and is it a good dividend stock?
BAJAJHCARE offers a dividend yield of 0.23%, meaning you receive ₹0.23 annual dividend for every ₹100 invested in Bajaj Healthcare Ltd shares.
How has BAJAJHCARE share price grown over the past 5 years?
BAJAJHCARE has achieved 5-year growth rates of: Sales Growth 5.76%, Profit Growth 9.56%, and EPS Growth 6.64%.
What is the promoter holding in BAJAJHCARE and why does it matter?
Promoters hold 59.19% of BAJAJHCARE shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Bajaj Healthcare Ltd.
What is BAJAJHCARE market capitalisation category?
BAJAJHCARE has a market capitalisation of ₹1354 crores, placing it in the Small-cap category.
How volatile is BAJAJHCARE stock?
BAJAJHCARE has a beta of N/A. A beta > 1 suggests the Bajaj Healthcare Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is BAJAJHCARE operating profit margin trend?
BAJAJHCARE has a 5-year average Operating Profit Margin (OPM) of 17.53%, indicating the company's operational efficiency.
How is BAJAJHCARE quarterly performance?
Recent quarterly performance shows Bajaj Healthcare Ltd YoY Sales Growth of 11.14% and YoY Profit Growth of 49.28%.
What is the institutional holding pattern in BAJAJHCARE?
BAJAJHCARE has FII holding of 1.12% and DII holding of 2.99%. Significant institutional holding often suggests professional confidence in the Bajaj Healthcare Ltd stock.